With the rapid development of the company's sales and R&D, the company's decision-makers began to carry out industrial acquisitions and mergers, and strived to turn Langsheng Pharmaceutical into an industrialized group company integrating R&D, production, sales and operation. At present, substantial progress has been made in industrial acquisition negotiations. Langsheng people are turning Langsheng into a listed company with advanced business philosophy and business model as its ideal life, developing steadfastly and steadily, and striving to open a new chapter.
In the next five years, we will move towards a higher goal: take 20 12 as an opportunity, base ourselves on business, acquire industries, and build listed public enterprises in five years. With the deepening of the reform of medical and health system in China, Langsheng Pharmaceutical will follow the trend and develop in the direction of standardization and scale.
In order to ensure the healthy development of the enterprise and achieve the established goals, Langsheng Pharmaceutical has carefully examined itself and put forward a two-step strategic policy: first, make use of the existing refined commercial operation platform to ensure sufficient profits for the industry, do a good job in the "shield" of work development, and realize the development and progress of * * * *; The second is to bring industrial varieties to the market as soon as possible through the sales platform of Langsheng Pharmaceutical. At present, although many domestic pharmaceutical companies have good products, the market development is often hindered by the lack of a good sales platform, and Langsheng Pharmaceutical has inherent advantages in this respect, which will undoubtedly play a huge role in promoting the future development of enterprises.